diabetes mellitus, type 2

Mizani, M. A., Dashtban, A., Pasea, L., Zeng, Q., Khunti, K., Valabhji, J., et al. (2024). Identifying subtypes of type 2 diabetes mellitus with machine learning: development, internal validation, prognostic validation and medication burden in linked electronic health records in 420 448 individuals. Bmj Open Diabetes Res Care, 12. http://doi.org/10.1136/bmjdrc-2024-004191
Doran, W., Tunnicliffe, L., Muzambi, R., Rentsch, C. T., Bhaskaran, K., Smeeth, L., et al. (2024). Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records. Bmj Open Diabetes Res Care, 12. http://doi.org/10.1136/bmjdrc-2023-003548
Pollock, C., Sanchez, J. J. G., Carrero, J. J., Kumar, S., Pecoits-Filho, R., Lam, C. S. P., et al. (2023). Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification. Diabet Med, e15200. http://doi.org/10.1111/dme.15200